| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 2.94e-07 | 6 | 50 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 2.94e-07 | 6 | 50 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 8.20e-07 | 8 | 50 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.23e-06 | 9 | 50 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 8.09e-06 | 16 | 50 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.63e-05 | 20 | 50 | 3 | GO:0070003 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 7.44e-07 | 8 | 50 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 1.34e-06 | 34 | 50 | 4 | GO:0043043 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.59e-06 | 10 | 50 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.59e-06 | 10 | 50 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 2.18e-06 | 11 | 50 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 2.90e-06 | 12 | 50 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 7.34e-06 | 16 | 50 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 1.48e-05 | 20 | 50 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.73e-05 | 21 | 50 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 2.00e-05 | 22 | 50 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 2.00e-05 | 22 | 50 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 2.97e-05 | 25 | 50 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 5.11e-05 | 84 | 50 | 4 | GO:0006518 | |
| GeneOntologyBiologicalProcess | spermatogenesis | SPATA31A1 SPATA31A3 GGN SPATA31A7 SHBG SPATA31A5 GGT2P GGT1 GGT3P | 6.55e-05 | 744 | 50 | 9 | GO:0007283 |
| GeneOntologyBiologicalProcess | male gamete generation | SPATA31A1 SPATA31A3 GGN SPATA31A7 SHBG SPATA31A5 GGT2P GGT1 GGT3P | 7.86e-05 | 762 | 50 | 9 | GO:0048232 |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 9.83e-05 | 37 | 50 | 3 | GO:0042219 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 1.24e-04 | 40 | 50 | 3 | GO:0000096 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.34e-04 | 41 | 50 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 1.54e-04 | 43 | 50 | 3 | GO:0009069 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 2.72e-04 | 52 | 50 | 3 | GO:1901570 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 2.72e-04 | 52 | 50 | 3 | GO:0042398 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 2.88e-04 | 53 | 50 | 3 | GO:0044273 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 4.80e-04 | 63 | 50 | 3 | GO:0006749 | |
| GeneOntologyBiologicalProcess | gamete generation | SPATA31A1 SPATA31A3 GGN SPATA31A7 SHBG SPATA31A5 GGT2P GGT1 GGT3P | 5.21e-04 | 982 | 50 | 9 | GO:0007276 |
| GeneOntologyBiologicalProcess | zymogen activation | 5.27e-04 | 65 | 50 | 3 | GO:0031638 | |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 5.76e-04 | 67 | 50 | 3 | GO:0046456 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 6.27e-04 | 69 | 50 | 3 | GO:0170038 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 6.54e-04 | 70 | 50 | 3 | GO:0170034 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 8.64e-04 | 77 | 50 | 3 | GO:1901607 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 9.06e-04 | 178 | 50 | 4 | GO:0044272 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by integrin | 9.59e-04 | 19 | 50 | 2 | GO:0033631 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.04e-03 | 82 | 50 | 3 | GO:1901568 | |
| GeneOntologyBiologicalProcess | sexual reproduction | SPATA31A1 SPATA31A3 GGN SPATA31A7 SHBG SPATA31A5 SYDE1 GGT2P GGT1 GGT3P | 1.04e-03 | 1312 | 50 | 10 | GO:0019953 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | 1.15e-03 | 878 | 50 | 8 | GO:0051336 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 1.19e-03 | 86 | 50 | 3 | GO:0008652 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 1.25e-03 | 499 | 50 | 6 | GO:0051345 | |
| GeneOntologyCellularComponent | RNA-directed RNA polymerase complex | 1.68e-05 | 3 | 50 | 2 | GO:0031379 | |
| MousePheno | abnormal circulating glutathione level | 1.43e-07 | 5 | 35 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 1.43e-07 | 5 | 35 | 3 | MP:0030653 | |
| MousePheno | increased glutathione level | 1.43e-07 | 5 | 35 | 3 | MP:0012606 | |
| MousePheno | glutathionuria | 1.43e-07 | 5 | 35 | 3 | MP:0013730 | |
| MousePheno | decreased circulating cysteine level | 5.00e-07 | 7 | 35 | 3 | MP:0030626 | |
| MousePheno | epididymis hypoplasia | 7.98e-07 | 8 | 35 | 3 | MP:0004932 | |
| MousePheno | decreased cysteine level | 7.98e-07 | 8 | 35 | 3 | MP:0030623 | |
| MousePheno | nervous | 1.20e-06 | 9 | 35 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 1.70e-06 | 10 | 35 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 1.70e-06 | 10 | 35 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 1.70e-06 | 10 | 35 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 2.34e-06 | 11 | 35 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 2.34e-06 | 11 | 35 | 3 | MP:0011130 | |
| MousePheno | abnormal cysteine level | 4.04e-06 | 13 | 35 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 4.04e-06 | 13 | 35 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 4.04e-06 | 13 | 35 | 3 | MP:0012603 | |
| MousePheno | priapism | 5.14e-06 | 14 | 35 | 3 | MP:0003415 | |
| MousePheno | decreased thyroxine level | 7.57e-06 | 51 | 35 | 4 | MP:0005471 | |
| MousePheno | abnormal copulatory plug deposition | 7.87e-06 | 16 | 35 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 7.87e-06 | 16 | 35 | 3 | MP:0008477 | |
| MousePheno | failure of superovulation | 1.14e-05 | 18 | 35 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 1.14e-05 | 18 | 35 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 1.14e-05 | 18 | 35 | 3 | MP:0009093 | |
| MousePheno | abnormal copulation physiology | 1.36e-05 | 19 | 35 | 3 | MP:0031627 | |
| MousePheno | increased circulating growth hormone level | 1.36e-05 | 19 | 35 | 3 | MP:0005123 | |
| MousePheno | abnormal thyroxine level | 2.13e-05 | 66 | 35 | 4 | MP:0005469 | |
| MousePheno | small vertebrae | 2.14e-05 | 22 | 35 | 3 | MP:0004610 | |
| MousePheno | increased growth hormone level | 2.46e-05 | 23 | 35 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 2.46e-05 | 23 | 35 | 3 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 2.81e-05 | 24 | 35 | 3 | MP:0009697 | |
| MousePheno | abnormal thyroid hormone level | 3.35e-05 | 74 | 35 | 4 | MP:0005468 | |
| MousePheno | nuclear cataract | 3.59e-05 | 26 | 35 | 3 | MP:0010254 | |
| MousePheno | aminoaciduria | 5.02e-05 | 29 | 35 | 3 | MP:0003311 | |
| MousePheno | decreased circulating pituitary hormone level | 6.91e-05 | 89 | 35 | 4 | MP:0005118 | |
| MousePheno | anovulation | 7.45e-05 | 33 | 35 | 3 | MP:0008869 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 8.16e-05 | 34 | 35 | 3 | MP:0002790 | |
| MousePheno | decreased amino acid level | 9.67e-05 | 97 | 35 | 4 | MP:0014528 | |
| MousePheno | decreased circulating estradiol level | 1.14e-04 | 38 | 35 | 3 | MP:0005181 | |
| MousePheno | decreased tertiary ovarian follicle number | 1.24e-04 | 39 | 35 | 3 | MP:0011129 | |
| MousePheno | decreased circulating estrogen level | 1.44e-04 | 41 | 35 | 3 | MP:0003371 | |
| MousePheno | abnormal limb morphology | COL7A1 CHST14 PIEZO1 FURIN CPLANE1 FAM20A GGT2P GGT1 GGT3P DYRK2 | 1.49e-04 | 1028 | 35 | 10 | MP:0002109 |
| MousePheno | induced hyperactivity | 1.54e-04 | 42 | 35 | 3 | MP:0008911 | |
| MousePheno | decreased pituitary hormone level | 1.75e-04 | 113 | 35 | 4 | MP:0003972 | |
| MousePheno | decreased follicle stimulating hormone level | 1.77e-04 | 44 | 35 | 3 | MP:0005130 | |
| MousePheno | decreased long bone epiphyseal plate size | 1.77e-04 | 44 | 35 | 3 | MP:0006396 | |
| MousePheno | absent estrous cycle | 1.77e-04 | 44 | 35 | 3 | MP:0009009 | |
| MousePheno | abnormal tertiary ovarian follicle number | 2.16e-04 | 47 | 35 | 3 | MP:0011127 | |
| MousePheno | abnormal amino acid derivative level | 2.57e-04 | 125 | 35 | 4 | MP:0021145 | |
| MousePheno | increased pituitary hormone level | 2.82e-04 | 128 | 35 | 4 | MP:0003973 | |
| MousePheno | abnormal circulating estradiol level | 2.92e-04 | 52 | 35 | 3 | MP:0005183 | |
| MousePheno | aciduria | 3.45e-04 | 55 | 35 | 3 | MP:0010028 | |
| MousePheno | abnormal vertebrae morphology | 3.46e-04 | 546 | 35 | 7 | MP:0000137 | |
| MousePheno | abnormal circulating estrogen level | 3.83e-04 | 57 | 35 | 3 | MP:0003369 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 3.83e-04 | 57 | 35 | 3 | MP:0009363 | |
| MousePheno | disproportionate dwarf | 3.83e-04 | 57 | 35 | 3 | MP:0002427 | |
| MousePheno | abnormal growth hormone level | 3.83e-04 | 57 | 35 | 3 | MP:0003968 | |
| MousePheno | abnormal urine amino acid level | 4.25e-04 | 59 | 35 | 3 | MP:0011468 | |
| MousePheno | immotile sperm | 4.25e-04 | 59 | 35 | 3 | MP:0020869 | |
| MousePheno | decreased circulating gonadotropin level | 4.46e-04 | 60 | 35 | 3 | MP:0003363 | |
| MousePheno | decreased circulating testosterone level | 4.46e-04 | 60 | 35 | 3 | MP:0002780 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 4.68e-04 | 61 | 35 | 3 | MP:0004701 | |
| MousePheno | impaired ovarian folliculogenesis | 4.68e-04 | 61 | 35 | 3 | MP:0001129 | |
| MousePheno | diluted coat color | 5.40e-04 | 64 | 35 | 3 | MP:0000371 | |
| MousePheno | abnormal vertebral column morphology | 5.89e-04 | 787 | 35 | 8 | MP:0004703 | |
| MousePheno | abnormal superovulation | 5.91e-04 | 66 | 35 | 3 | MP:0009648 | |
| MousePheno | absent corpus luteum | 5.91e-04 | 66 | 35 | 3 | MP:0001134 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 6.45e-04 | 68 | 35 | 3 | MP:0003662 | |
| MousePheno | small epididymis | 7.02e-04 | 70 | 35 | 3 | MP:0004930 | |
| MousePheno | limbs/digits/tail phenotype | COL7A1 CHST14 PIEZO1 FURIN CPLANE1 FAM20A GGT2P GGT1 GGT3P DYRK2 | 7.60e-04 | 1258 | 35 | 10 | MP:0005371 |
| MousePheno | abnormal circulating insulin-like growth factor I level | 7.62e-04 | 72 | 35 | 3 | MP:0004700 | |
| MousePheno | abnormal insulin-like growth factor I level | 8.58e-04 | 75 | 35 | 3 | MP:0008831 | |
| MousePheno | abnormal circulating pituitary hormone level | 8.60e-04 | 172 | 35 | 4 | MP:0005116 | |
| MousePheno | short rostral-caudal axis | 9.09e-04 | 18 | 35 | 2 | MP:0012173 | |
| MousePheno | increased osteoclast cell number | 9.26e-04 | 77 | 35 | 3 | MP:0004984 | |
| MousePheno | hindlimb paralysis | 9.98e-04 | 79 | 35 | 3 | MP:0000755 | |
| MousePheno | limb paralysis | 1.15e-03 | 83 | 35 | 3 | MP:0013147 | |
| MousePheno | decreased circulating amino acid level | 1.17e-03 | 187 | 35 | 4 | MP:0014531 | |
| MousePheno | abnormal circulating testosterone level | 1.19e-03 | 84 | 35 | 3 | MP:0005180 | |
| MousePheno | abnormal circulating androgen level | 1.19e-03 | 84 | 35 | 3 | MP:0009819 | |
| MousePheno | abnormal long bone morphology | 1.23e-03 | 676 | 35 | 7 | MP:0003723 | |
| MousePheno | abnormal appendicular skeleton morphology | 1.38e-03 | 896 | 35 | 8 | MP:0009250 | |
| MousePheno | abnormal follicle stimulating hormone level | 1.41e-03 | 89 | 35 | 3 | MP:0003967 | |
| MousePheno | abnormal testosterone level | 1.55e-03 | 92 | 35 | 3 | MP:0011385 | |
| MousePheno | small uterus | 1.55e-03 | 92 | 35 | 3 | MP:0002637 | |
| MousePheno | abnormal sexual interaction | 1.65e-03 | 94 | 35 | 3 | MP:0002566 | |
| MousePheno | abnormal ovulation | 1.80e-03 | 97 | 35 | 3 | MP:0001928 | |
| MousePheno | abnormal reproductive system development | 1.91e-03 | 99 | 35 | 3 | MP:0003936 | |
| MousePheno | abnormal pituitary hormone level | 1.93e-03 | 214 | 35 | 4 | MP:0003965 | |
| MousePheno | decreased bone mass | 1.97e-03 | 100 | 35 | 3 | MP:0004016 | |
| MousePheno | decreased somite size | 2.21e-03 | 28 | 35 | 2 | MP:0011732 | |
| MousePheno | abnormal tibia morphology | 2.26e-03 | 375 | 35 | 5 | MP:0000558 | |
| MousePheno | abnormal axial skeleton morphology | CHST14 CNTNAP1 R3HDM1 CPLANE1 FAM20A TERT GGT2P GGT1 GGT3P DYRK2 | 2.36e-03 | 1458 | 35 | 10 | MP:0002114 |
| MousePheno | small seminiferous tubules | 2.39e-03 | 107 | 35 | 3 | MP:0001153 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 2.43e-03 | 381 | 35 | 5 | MP:0003857 | |
| MousePheno | kyphosis | 2.47e-03 | 229 | 35 | 4 | MP:0000160 | |
| MousePheno | increased circulating pituitary hormone level | 2.58e-03 | 110 | 35 | 3 | MP:0005117 | |
| MousePheno | abnormal spleen red pulp morphology | 2.58e-03 | 110 | 35 | 3 | MP:0002356 | |
| MousePheno | abnormal seminiferous tubule size | 2.65e-03 | 111 | 35 | 3 | MP:0006307 | |
| MousePheno | abnormal circulating gonadotropin level | 2.72e-03 | 112 | 35 | 3 | MP:0003361 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 2.79e-03 | 113 | 35 | 3 | MP:0000165 | |
| Domain | DUF4599 | 3.23e-06 | 12 | 47 | 3 | PF15371 | |
| Domain | DUF4599 | 3.23e-06 | 12 | 47 | 3 | IPR027970 | |
| Domain | GGT_peptidase | 1.29e-04 | 7 | 47 | 2 | IPR000101 | |
| Domain | G_glu_transpept | 1.29e-04 | 7 | 47 | 2 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 1.29e-04 | 7 | 47 | 2 | PS00462 | |
| Domain | LAM_G_DOMAIN | 4.11e-03 | 38 | 47 | 2 | PS50025 | |
| Domain | LamG | 5.48e-03 | 44 | 47 | 2 | SM00282 | |
| Domain | Laminin_G | 9.37e-03 | 58 | 47 | 2 | IPR001791 | |
| Domain | RhoGAP | 1.06e-02 | 62 | 47 | 2 | SM00324 | |
| Domain | RhoGAP | 1.10e-02 | 63 | 47 | 2 | PF00620 | |
| Domain | RHOGAP | 1.13e-02 | 64 | 47 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 1.13e-02 | 64 | 47 | 2 | IPR000198 | |
| Domain | - | 1.13e-02 | 64 | 47 | 2 | 1.10.555.10 | |
| Domain | Kinase-like_dom | 1.14e-02 | 542 | 47 | 5 | IPR011009 | |
| Domain | Ser/Thr_kinase_AS | 1.23e-02 | 357 | 47 | 4 | IPR008271 | |
| Domain | S_TKc | 1.25e-02 | 359 | 47 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.29e-02 | 362 | 47 | 4 | PS00108 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 8.37e-06 | 16 | 36 | 3 | MM14680 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 2.28e-05 | 22 | 36 | 3 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 2.98e-05 | 24 | 36 | 3 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.38e-05 | 25 | 36 | 3 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 3.82e-05 | 26 | 36 | 3 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 4.29e-05 | 27 | 36 | 3 | MM15908 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 7.92e-05 | 33 | 36 | 3 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 9.46e-05 | 35 | 36 | 3 | MM15815 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.21e-04 | 38 | 36 | 3 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.31e-04 | 39 | 36 | 3 | MM15695 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 4.86e-04 | 13 | 36 | 2 | M46426 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 4.97e-04 | 61 | 36 | 3 | MM14861 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 8.90e-04 | 170 | 36 | 4 | MM15573 | |
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 5.66e-11 | 6 | 50 | 4 | 25930072 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 2.80e-09 | 3 | 50 | 3 | 2573352 | |
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 2.79e-08 | 5 | 50 | 3 | 18063838 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 2.79e-08 | 5 | 50 | 3 | 11095909 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 7641802 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 23615310 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 9627710 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 12453183 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 11003618 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 10392451 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 2891746 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 2.79e-08 | 5 | 50 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 2.79e-08 | 5 | 50 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 2.79e-08 | 5 | 50 | 3 | 11089562 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 2.79e-08 | 5 | 50 | 3 | 12468440 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 2.79e-08 | 5 | 50 | 3 | 12225953 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 7775425 | ||
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 2.79e-08 | 5 | 50 | 3 | 8566783 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 30591459 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 9139708 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 2.79e-08 | 5 | 50 | 3 | 9546365 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 11795900 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 2.79e-08 | 5 | 50 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 2.79e-08 | 5 | 50 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 2.79e-08 | 5 | 50 | 3 | 24698228 | |
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 2.79e-08 | 5 | 50 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 2.79e-08 | 5 | 50 | 3 | 19760322 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 10474818 | ||
| Pubmed | 3.93e-08 | 24 | 50 | 4 | 32212159 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 14634009 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 17363454 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 5.57e-08 | 6 | 50 | 3 | 8101000 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 8663190 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 5.57e-08 | 6 | 50 | 3 | 8104871 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 11463821 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 25326709 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 12163373 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 22242126 | ||
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 27775020 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 9.75e-08 | 7 | 50 | 3 | 32284594 | |
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 9.75e-08 | 7 | 50 | 3 | 1968405 | |
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 36685533 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 23863468 | ||
| Pubmed | 1.01e-06 | 14 | 50 | 3 | 18357469 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 14744861 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25180444 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35347031 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25280803 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 37904480 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23682772 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 2.25e-06 | 18 | 50 | 3 | 17097888 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 39441936 | ||
| Pubmed | 7.98e-06 | 27 | 50 | 3 | 18478268 | ||
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 9.95e-06 | 29 | 50 | 3 | 22424930 | |
| Pubmed | Dichotomy between the transcriptomic landscape of naturally versus accelerated aged murine hearts. | 1.21e-05 | 4 | 50 | 2 | 32424227 | |
| Pubmed | Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. | 2.02e-05 | 5 | 50 | 2 | 2904146 | |
| Pubmed | Expression of multiple gamma-glutamyltransferase genes in man. | 2.02e-05 | 5 | 50 | 2 | 7906515 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 10729222 | ||
| Pubmed | 2.28e-05 | 38 | 50 | 3 | 27820600 | ||
| Pubmed | Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation. | 3.03e-05 | 6 | 50 | 2 | 23362280 | |
| Pubmed | 3.55e-05 | 44 | 50 | 3 | 16332269 | ||
| Pubmed | A comprehensive analysis of 22q11 gene expression in the developing and adult brain. | 3.80e-05 | 45 | 50 | 3 | 14614146 | |
| Pubmed | Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy. | 4.61e-05 | 137 | 50 | 4 | 30862715 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 9169155 | ||
| Pubmed | 7.34e-05 | 56 | 50 | 3 | 20096683 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 9417917 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.37e-04 | 552 | 50 | 6 | 10737800 | |
| Pubmed | 2.40e-04 | 16 | 50 | 2 | 38448588 | ||
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 24647736 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.92e-04 | 1201 | 50 | 8 | 35696571 | |
| Pubmed | 3.53e-04 | 95 | 50 | 3 | 20843830 | ||
| Pubmed | Report of the sixth international workshop on human chromosome 3 mapping 1995. | 4.18e-04 | 21 | 50 | 2 | 8641130 | |
| Pubmed | 9.77e-04 | 32 | 50 | 2 | 23154389 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.24e-03 | 560 | 50 | 5 | 21653829 | |
| Pubmed | 1.25e-03 | 147 | 50 | 3 | 26465331 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.42e-03 | 861 | 50 | 6 | 36931259 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.24e-05 | 8 | 50 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 3.16e-04 | 24 | 50 | 2 | 9p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 1.13e-03 | 419 | 50 | 4 | chr22q11 | |
| Cytoband | 22q11.23 | 1.55e-03 | 53 | 50 | 2 | 22q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.81e-03 | 1192 | 50 | 6 | chr19q13 | |
| Cytoband | 22q11.21 | 6.58e-03 | 111 | 50 | 2 | 22q11.21 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 6.62e-07 | 13 | 25 | 3 | 564 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP | 1.95e-06 | 200 | 49 | 6 | M3523 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-06 | 190 | 50 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-05 | 153 | 50 | 4 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.61e-05 | 166 | 50 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 167 | 50 | 4 | 3c06894fc6177f3c204094719904da42f08b9af8 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 4.43e-05 | 175 | 50 | 4 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 4.43e-05 | 175 | 50 | 4 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 176 | 50 | 4 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 176 | 50 | 4 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.73e-05 | 178 | 50 | 4 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.73e-05 | 178 | 50 | 4 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.27e-05 | 183 | 50 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.74e-05 | 195 | 50 | 4 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.88e-05 | 196 | 50 | 4 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | severe-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.44e-05 | 200 | 50 | 4 | 2e67068b98696c313b815a2f0c98643f892e8bc0 | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; MCF7; HT_HG-U133A | 3.20e-06 | 198 | 47 | 6 | 6501_DN | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.24e-07 | 7 | 46 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.97e-07 | 8 | 46 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | gastric ulcer | 4.90e-04 | 21 | 46 | 2 | EFO_0009454 | |
| Disease | diastolic blood pressure, unipolar depression | 1.01e-03 | 30 | 46 | 2 | EFO_0003761, EFO_0006336 | |
| Disease | melanoma (is_marker_for) | 1.22e-03 | 33 | 46 | 2 | DOID:1909 (is_marker_for) | |
| Disease | platelet measurement | 1.46e-03 | 315 | 46 | 4 | EFO_0005036 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQEEQQRHRPSPWRV | 156 | Q9BXH1 | |
| QLGRWVPRLREPRDL | 61 | Q8NEM8 | |
| QARLRVDHRPWVLRP | 886 | P78357 | |
| RRLVPNFRWAIPNRH | 56 | Q9NWD9 | |
| RNRLPGNLFQRWHVP | 31 | O95831 | |
| HRDLRTGRWEPDPQR | 66 | P51693 | |
| ERLIEWLPLHLPRQQ | 441 | Q6JQN1 | |
| PLWRRRSIPQPHQVL | 16 | Q96DR7 | |
| VHGQLRILWRRPSQP | 221 | Q0PNE2 | |
| RILWRRPSQPAVHRD | 226 | Q0PNE2 | |
| SGHLPRDPELRDWRR | 511 | A1A5B4 | |
| RWLRDPQSQPRRHPL | 1016 | Q15032 | |
| QRHGRLPWARLFQPS | 146 | A6NGU5 | |
| QPRHRRLPRNVSAWL | 601 | Q86UU5 | |
| LWNNVRRGARPERLP | 861 | Q6XUX3 | |
| REPLLPRIAWAHPRR | 26 | Q8TCG2 | |
| LVRSRRPQPPNWGHL | 6 | O00110 | |
| VERHQLIINPRGWRP | 136 | P25929 | |
| LIINPRGWRPNNRHA | 141 | P25929 | |
| HAVQLRWGPRRRPPL | 11 | P08648 | |
| RPTPQDWLHRRAQIL | 811 | O75173 | |
| LHRLNFPRRAQGPTW | 471 | Q9BYW1 | |
| NPVQQPGHRLLILWR | 756 | Q9H799 | |
| PLPNEAWVALRRRHP | 236 | Q96CD0 | |
| RPRHSRLQREPQVQW | 81 | P09958 | |
| HSLRLRWEPVPRAQG | 881 | Q02388 | |
| PGQALRHPWLRRRLP | 526 | Q92630 | |
| QRHGRLPWARLFQPS | 146 | P36268 | |
| GRPRRKGPRWHIDLQ | 101 | Q5JXM2 | |
| ALVLAWDPGVRRHRP | 331 | Q6ZW31 | |
| RPIAQWHSLRPPDRV | 366 | O00445 | |
| PRRARRIPPHVLVNW | 226 | Q5TCX8 | |
| ALRRDPNLPVHIRGW | 46 | Q9H4M7 | |
| HLWPQVQRQLRPRER | 26 | Q96MK3 | |
| QHPEWPLLRRQLEGR | 541 | Q8IWB4 | |
| LRHTRQGWALRPVLP | 21 | P04278 | |
| PWDLPVGQRRTLLRH | 126 | Q8NCH0 | |
| QHPEWPLLRRQLEGR | 541 | Q5VYP0 | |
| EWGLARVAQPRLRQP | 571 | Q8TCY9 | |
| RRWAEDVPPQRLDGH | 341 | Q03169 | |
| DQWHEIRQGRLPRIP | 521 | P30291 | |
| QHPEWPLLRRQLEGR | 541 | Q5TZJ5 | |
| QHPEWPLLRRQLEGR | 541 | Q5VU36 | |
| GLRHPRINVLDPGQW | 576 | Q9P2E3 | |
| RQHPGRRAAWVREPL | 226 | P20396 | |
| LPGTRLPRWAHRQDA | 716 | Q92508 | |
| LHPERGIRQWAPARQ | 91 | Q6DKI7 | |
| RLVPPGLWGSRHNER | 471 | O14746 | |
| LLRAGVPREHRPRVW | 621 | Q9BYX2 | |
| WVIRQPVHRGHPRLL | 446 | Q5TIE3 | |
| QRHGRLPWARLFQPS | 146 | P19440 | |
| HRVLLWPRRAQDEHP | 86 | Q13459 |